Mark Loeb, ACC 2022: IVVE: Randomized controlled trial of influenza vaccine in patients with heart failure to reduce adverse vascular events
The IVVE study is a randomized controlled trial of influenza vaccine in patients with heart failure to reduce adverse vascular events. It was delightful to speak with Prof Mark Loeb (McMaster University, Hamilton, Canada) about his presentation at the American College of Cardiology Annual Meeting 2022.
- What is known about the effects of the influenza vaccine on mortality and cardiovascular outcomes in patients with heart failure? (00:22)
- What were the aims and design of the IVVE study? (01:22)
- What were the primary outcome findings of the study? (03:00)
- Were any other variables found to modify the benefits of vaccination? (04:36)
- On the basis of these findings, what are your recommendations for future clinical practice? (05:15)
Disclosures: Mark Loeb discloses grant/research support from CIHR, WHO and Seqirus.
Support: Interview and filming supported by Touch Medical Media Ltd. Interview conducted by Shanice Allen.
Filmed in coverage of the American College of Cardiology Annual Meeting 2022
Share this Video
Related Videos In Heart Failure
Gregg Stone, ACC 2023: COAPT trial results – Transcatheter edge-to-edge repair with MitraClip device for functional mitral regurgitation in heart failure
The COAPT trial investigated the use of the MitraClip a novel device for patients with secondary mitral regurgitation, a condition in which blood leaks backward through the mitral valve into the left atrium of the heart. In this touchCARDIO interview Dr Gregg Stone (Mount Sinai Heart Health System, New York City, NY, USA) discusses the […]
John Boehmer, ACC 2023: MicrocorTM device for heart failure management, the BMAD trial
The BMAD trial investigated patients with heart failure assessed the use of the Microcor device on readmission rates. In this touchCARDIO interview, we speak with Dr John Boehmer (Penn State Milton S Hershey Medical Center, Penn State College of Medicine, Hershey, PA, USA) to discuss purpose, findings and clinical implications of the BMAD trial in […]
John Boehmer, ACC 2023: The MicrocorTM device, monitoring tool for heart failure
The most common cause of hospital admission due to heart failure is due to excess fluid retention. The MicrocorTM device monitors fluid levels in the lungs to aid in patient management. In this touchCARDIO interview, we speak with Dr John Boehmer (Penn State Milton S Hershey Medical Center, Penn State College of Medicine, Hershey, PA, […]
Journal articles and more to your inbox
Get the latest clinical insights from touchCARDIOSign me up!